pubmed-article:7889813 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7889813 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:7889813 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:7889813 | lifeskim:mentions | umls-concept:C0025605 | lld:lifeskim |
pubmed-article:7889813 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
pubmed-article:7889813 | lifeskim:mentions | umls-concept:C0588202 | lld:lifeskim |
pubmed-article:7889813 | lifeskim:mentions | umls-concept:C2827364 | lld:lifeskim |
pubmed-article:7889813 | lifeskim:mentions | umls-concept:C1701901 | lld:lifeskim |
pubmed-article:7889813 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:7889813 | pubmed:dateCreated | 1995-4-20 | lld:pubmed |
pubmed-article:7889813 | pubmed:abstractText | Two studies utilized within-subjects designs to determine whether take-home methadone doses can reinforce adjunct therapy attendance of drug abuse patients. These studies varied the reinforcement density and the schedule of methadone take-home doses. In Study 1, patients (n = 10) either could or could not receive a take-home following each therapy session. Study 2 patients (n = 15) could either earn take-homes following each therapy session attended (i.e., 2 take-homes per week) or could earn one take-home dose following each attendance to two consecutive sessions attended. In both studies experimental conditions alternated during three-week blocks of time. Across studies, any reinforcement by take-home doses produced more attendance at therapy sessions than that observed in the no reinforcement condition. Take-home incentive effects were strongest when each of the two weekly therapy sessions was reinforced by a methadone take-home dose. Increased attendance was not associated with reduced drug use, due perhaps to high rates of pre-study drug use and limited therapy duration. Contemporary opioid abusers present with multiple problems that methadone was never intended to treat. The present studies illustrate a method by which methadone treatment can improve the likelihood of delivering other services that may prove effective in treating some of these problems. | lld:pubmed |
pubmed-article:7889813 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7889813 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7889813 | pubmed:language | eng | lld:pubmed |
pubmed-article:7889813 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7889813 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:7889813 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7889813 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7889813 | pubmed:month | Dec | lld:pubmed |
pubmed-article:7889813 | pubmed:issn | 0376-8716 | lld:pubmed |
pubmed-article:7889813 | pubmed:author | pubmed-author:GoldbergJJ | lld:pubmed |
pubmed-article:7889813 | pubmed:author | pubmed-author:StitzerM LML | lld:pubmed |
pubmed-article:7889813 | pubmed:author | pubmed-author:BroonerR KRK | lld:pubmed |
pubmed-article:7889813 | pubmed:author | pubmed-author:KidorfMM | lld:pubmed |
pubmed-article:7889813 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7889813 | pubmed:volume | 36 | lld:pubmed |
pubmed-article:7889813 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7889813 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7889813 | pubmed:pagination | 221-6 | lld:pubmed |
pubmed-article:7889813 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:7889813 | pubmed:meshHeading | pubmed-meshheading:7889813-... | lld:pubmed |
pubmed-article:7889813 | pubmed:meshHeading | pubmed-meshheading:7889813-... | lld:pubmed |
pubmed-article:7889813 | pubmed:meshHeading | pubmed-meshheading:7889813-... | lld:pubmed |
pubmed-article:7889813 | pubmed:meshHeading | pubmed-meshheading:7889813-... | lld:pubmed |
pubmed-article:7889813 | pubmed:meshHeading | pubmed-meshheading:7889813-... | lld:pubmed |
pubmed-article:7889813 | pubmed:meshHeading | pubmed-meshheading:7889813-... | lld:pubmed |
pubmed-article:7889813 | pubmed:meshHeading | pubmed-meshheading:7889813-... | lld:pubmed |
pubmed-article:7889813 | pubmed:meshHeading | pubmed-meshheading:7889813-... | lld:pubmed |
pubmed-article:7889813 | pubmed:meshHeading | pubmed-meshheading:7889813-... | lld:pubmed |
pubmed-article:7889813 | pubmed:meshHeading | pubmed-meshheading:7889813-... | lld:pubmed |
pubmed-article:7889813 | pubmed:meshHeading | pubmed-meshheading:7889813-... | lld:pubmed |
pubmed-article:7889813 | pubmed:meshHeading | pubmed-meshheading:7889813-... | lld:pubmed |
pubmed-article:7889813 | pubmed:meshHeading | pubmed-meshheading:7889813-... | lld:pubmed |
pubmed-article:7889813 | pubmed:meshHeading | pubmed-meshheading:7889813-... | lld:pubmed |
pubmed-article:7889813 | pubmed:meshHeading | pubmed-meshheading:7889813-... | lld:pubmed |
pubmed-article:7889813 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:7889813 | pubmed:articleTitle | Contingent methadone take-home doses reinforce adjunct therapy attendance of methadone maintenance patients. | lld:pubmed |
pubmed-article:7889813 | pubmed:affiliation | Johns Hopkins University School of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD. | lld:pubmed |
pubmed-article:7889813 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:7889813 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:7889813 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:7889813 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:7889813 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7889813 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7889813 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7889813 | lld:pubmed |